National Cancer Institute
University of Western Ontario
Innovascreen has received important funding from the Atlantic Canada Opportunities Agency under the Business Development Program. This money will be used for the continued development of the Fusogenix Platform.
Innovascreen has received funding under the National Research Council of Canada’s Industry Research Assistance Program (IRAP). This money will be used for continued development of the Fusogenix Platform.